FENC Presents New PEDMARK Research at 2026 ASCO, Shows Safe Use in AYA and Adult Populations, +Significant Reduction in Cisplatin-Induced Ototoxicity
Fennec Pharmaceuticals Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $9.88
-0.4% in 1d after detection
Post-detection moves
1h
—
1d
-0.4%
3d
-0.4%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS